H Potschka Selected Research

Epilepsy (Aura)

1/2023	Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy.
5/2015	Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.
7/2010	Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy.
1/2004	Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures.
1/2003	N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy.
1/2002	Effect of phenytoin on sodium and calcium currents in hippocampal CA1 neurons of phenytoin-resistant kindled rats.
11/2001	P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain.
8/2001	Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain.
8/2001	Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy.
7/2001	In vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na(+) channels.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Potschka Research Topics

Disease

12	Epilepsy (Aura) 01/2023 - 02/2000
9	Seizures (Absence Seizure) 05/2015 - 02/2000
8	Temporal Lobe Epilepsy 05/2015 - 02/2000
5	Status Epilepticus (Complex Partial Status Epilepticus) 02/2009 - 08/2001
1	Poisoning 04/2017
1	Distemper (Canine Distemper) 08/2012
1	Infections 08/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2011
1	Alzheimer Disease (Alzheimer's Disease) 08/2011
1	Memory Disorders (Memory Loss) 09/2010
1	Ataxia (Dyssynergia) 04/2008

Drug/Important Bio-Agent (IBA)

5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2011 - 11/2001
5	Anticonvulsants (Antiepileptic Drugs)IBA 09/2010 - 09/2000
3	Pilocarpine (Ocusert)FDA LinkGeneric 09/2006 - 08/2001
3	Kainic Acid (Kainate)IBA 09/2006 - 01/2003
2	EndocannabinoidsIBA 05/2015 - 01/2015
2	gamma-Aminobutyric Acid (GABA)IBA 09/2006 - 02/2000
2	Multidrug Resistance-Associated ProteinsIBA 11/2001 - 08/2001
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2023
1	CannabinoidsIBA 01/2023
1	PoisonsIBA 04/2017
1	Monoacylglycerol LipasesIBA 05/2015
1	JZL 184IBA 05/2015
1	EnzymesIBA 05/2015
1	LectinsIBA 08/2012
1	Caspase 3 (Caspase-3)IBA 08/2012
1	Celecoxib (Celebrex)FDA Link 07/2010
1	Phenobarbital (Luminal)FDA Link 07/2010
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2010
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 04/2008
1	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 04/2008
1	Protein Isoforms (Isoforms)IBA 09/2006
1	Messenger RNA (mRNA)IBA 09/2006
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 09/2006
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2003
1	SodiumIBA 01/2002
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2002
1	LithiumIBA 08/2001
1	irampanelIBA 07/2001
1	Glutamate Receptors (Glutamate Receptor)IBA 07/2001
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 07/2001
1	ConvulsantsIBA 09/2000
1	Analgesics (Analgesic Drugs)IBA 09/2000
1	Dihydrotachysterol (AT 10)IBA 09/2000
1	Tramadol (K315)FDA LinkGeneric 09/2000
1	Gabapentin (Neurontin)FDA LinkGeneric 02/2000
1	LactamsIBA 02/2000

Therapy/Procedure

1	Off-Label Use 04/2017
1	Drug Therapy (Chemotherapy) 11/2001